Multiple sclerosis patients given PBS lifeline amid drug pricing dispute
Life-changing drugs used to treat multiple sclerosis (MS) will remain subsidised for Australians as Labor pledges to resolve…
PBS dispute could see MS patients pay thousands for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Broken PBS system behind failure to list Mounjaro for type 2 diabetics, according to Medicines Australia
Hundreds of thousands of Australians with diabetes will continue paying thousands of dollars a year for lifesaving medication…
Painkillers and HRT therapies among drugs not being subsidised under PBS
Patients are being hit with excessive costs on a range of everyday prescription medicines because of flaws in…
Major update on $25 PBS cap to make medicine cheaper for millions
New legislation would cap the cost of PBS medicines to $25, down from $31.60, from January 1. The…